eLaws | eCases | United States Code | Federal Courts |
Home » Rulemaking » Roche Diagnostics - Comment

Roche Diagnostics - Comment

Document ID: FDA-2012-D-1145-0011
Document Type: Public Submission
Agency: Food And Drug Administration
Received Date: March 11 2013, at 12:00 AM Eastern Daylight Time
Date Posted: March 19 2013, at 12:00 AM Eastern Standard Time
Comment Start Date: February 4 2013, at 12:00 AM Eastern Standard Time
Comment Due Date: March 18 2013, at 11:59 PM Eastern Standard Time
Tracking Number: 1jx-8452-m680
View Document:  View as format xml

View Comment

Roche Diagnostics respectfully submits the attached comments on Draft Guidance for Industry on Enrichment Strategies for Clinical Trials to Support Approval of Human Drugs and Biological Products.

Attachments:

Roche Diagnostics Comment

Title:
Roche Diagnostics Comment

View Attachment: View as format pdf

Related Comments

    View All
Total: 24
Roche Diagnostics - Comment
Public Submission    Posted: 03/19/2013     ID: FDA-2012-D-1145-0011

Mar 18,2013 11:59 PM ET
Robert A. Beckman - Comment
Public Submission    Posted: 03/19/2013     ID: FDA-2012-D-1145-0006

Mar 18,2013 11:59 PM ET
Living Well Black Inc (LWB) - Comment
Public Submission    Posted: 03/19/2013     ID: FDA-2012-D-1145-0027

Mar 18,2013 11:59 PM ET
AbbVie - Comment
Public Submission    Posted: 03/19/2013     ID: FDA-2012-D-1145-0019

Mar 18,2013 11:59 PM ET
Eli Lilly and Company - Comment
Public Submission    Posted: 03/19/2013     ID: FDA-2012-D-1145-0020

Mar 18,2013 11:59 PM ET